| scholarly article | Q13442814 |
| P2093 | author name string | Rob Ruijtenbeek | |
| Arjen Koppen | |||
| Eric Kalkhoven | |||
| Dirk Pijnenburg | |||
| Ellen H Jeninga | |||
| Rene Houtman | |||
| P2860 | cites work | Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes | Q22250883 |
| Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor | Q24321752 | ||
| Isoforms of steroid receptor co-activator 1 differ in their ability to potentiate transcription by the oestrogen receptor | Q24532913 | ||
| PPAR delta: a dagger in the heart of the metabolic syndrome | Q24541527 | ||
| Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis | Q24541529 | ||
| Solution structure of the zinc finger HIT domain in protein FON | Q27646889 | ||
| A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis | Q27860471 | ||
| The nuclear receptor superfamily: the second decade | Q27860725 | ||
| A signature motif in transcriptional co-activators mediates binding to nuclear receptors | Q27860938 | ||
| Isolation and characterization of peroxisome proliferator-activated receptor (PPAR) interacting protein (PRIP) as a coactivator for PPAR | Q28143258 | ||
| Ligand type-specific interactions of peroxisome proliferator-activated receptor gamma with transcriptional coactivators | Q28143758 | ||
| Small heterodimer partner, an orphan nuclear receptor, augments peroxisome proliferator-activated receptor gamma transactivation | Q28204021 | ||
| Coregulator function: a key to understanding tissue specificity of selective receptor modulators | Q28242935 | ||
| Isolation and characterization of PBP, a protein that interacts with peroxisome proliferator-activated receptor | Q28250779 | ||
| Docking interactions in protein kinase and phosphatase networks | Q28271644 | ||
| A regulatory role for RIP140 in nuclear receptor activation | Q28273693 | ||
| Principles for modulation of the nuclear receptor superfamily | Q28291197 | ||
| The PPARs: from orphan receptors to drug discovery | Q28371618 | ||
| p300 interacts with the N- and C-terminal part of PPARgamma2 in a ligand-independent and -dependent manner, respectively | Q28609750 | ||
| 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma | Q29615221 | ||
| Fat and beyond: the diverse biology of PPARgamma | Q29615416 | ||
| An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma) | Q29615693 | ||
| Multivalent engagement of chromatin modifications by linked binding modules | Q29617236 | ||
| Peroxisome-Proliferator-Activated Receptor δ Activates Fat Metabolism to Prevent Obesity | Q29619156 | ||
| Peptide antagonists of the human estrogen receptor | Q30633677 | ||
| Selection of estrogen receptor beta- and thyroid hormone receptor beta-specific coactivator-mimetic peptides using recombinant peptide libraries | Q30870457 | ||
| Correlation between in vitro peptide binding profiles and cellular activities for estrogen receptor-modulating compounds. | Q31049377 | ||
| Automated yeast two-hybrid screening for nuclear receptor-interacting proteins | Q33209988 | ||
| The nuclear receptor-coactivator interaction surface as a target for peptide antagonists of the peroxisome proliferator-activated receptors | Q33289042 | ||
| A canonical structure for the ligand-binding domain of nuclear receptors | Q61818643 | ||
| Stoichiometric and steric principles governing repression by nuclear hormone receptors | Q73231880 | ||
| The use of in vitro peptide binding profiles and in silico ligand-receptor interaction profiles to describe ligand-induced conformations of the retinoid X receptor alpha ligand-binding domain | Q79233699 | ||
| Chemoprevention of breast cancer with selective oestrogen-receptor modulators | Q79448439 | ||
| Protein-tyrosine kinase activity profiling in knock down zebrafish embryos | Q33289953 | ||
| The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors | Q33881484 | ||
| Ty element-induced temperature-sensitive mutations of Saccharomyces cerevisiae | Q33959712 | ||
| Activating and inactivating hormone receptor mutations. | Q34022263 | ||
| Coregulator codes of transcriptional regulation by nuclear receptors | Q34311570 | ||
| Use of homogeneous time-resolved fluorescence energy transfer in the measurement of nuclear receptor activation | Q34370596 | ||
| An improved high throughput protein-protein interaction assay for nuclear hormone receptors | Q35753577 | ||
| Peroxisome proliferator-activated receptor-gamma calls for activation in moderation: lessons from genetics and pharmacology | Q35975460 | ||
| The many faces of PPARgamma | Q36344625 | ||
| Estrogen receptor (ER) modulators each induce distinct conformational changes in ER alpha and ER beta. | Q36456030 | ||
| Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer | Q36684234 | ||
| Selective Modulators of PPAR-gamma Activity: Molecular Aspects Related to Obesity and Side-Effects | Q36772301 | ||
| SERMs for the treatment and prevention of breast cancer | Q36794420 | ||
| Cloning and identification of mouse steroid receptor coactivator-1 (mSRC-1), as a coactivator of peroxisome proliferator-activated receptor gamma. | Q36847488 | ||
| Functional peptide arrays for high-throughput chemical biology based applications | Q36903235 | ||
| Nuclear receptor coregulators: judges, juries, and executioners of cellular regulation | Q36931106 | ||
| Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials | Q36955489 | ||
| RAR and RXR modulation in cancer and metabolic disease | Q36956230 | ||
| Nuclear receptors: decoding metabolic disease | Q37006389 | ||
| Thyroid hormone receptor interacting protein 3 (trip3) is a novel coactivator of hepatocyte nuclear factor-4alpha. | Q38290830 | ||
| The peroxisome proliferator-activated receptor N-terminal domain controls isotype-selective gene expression and adipogenesis | Q38314801 | ||
| Peroxisome proliferator-activated receptor subtype- and cell-type-specific activation of genomic target genes upon adenoviral transgene delivery | Q38407726 | ||
| The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes | Q39451469 | ||
| The orphan nuclear receptor DAX-1 acts as a novel transcriptional corepressor of PPARgamma | Q39996370 | ||
| The adipogenic acetyltransferase Tip60 targets activation function 1 of peroxisome proliferator-activated receptor gamma | Q40032475 | ||
| Impaired peroxisome proliferator-activated receptor gamma function through mutation of a conserved salt bridge (R425C) in familial partial lipodystrophy. | Q40168723 | ||
| Tyrosine agonists reverse the molecular defects associated with dominant-negative mutations in human peroxisome proliferator-activated receptor gamma. | Q40610299 | ||
| A dominant-negative peroxisome proliferator-activated receptor gamma (PPARgamma) mutant is a constitutive repressor and inhibits PPARgamma-mediated adipogenesis | Q40899355 | ||
| Molecular characterization of new selective peroxisome proliferator-activated receptor gamma modulators with angiotensin receptor blocking activity | Q42807756 | ||
| Multiplexed molecular interactions of nuclear receptors using fluorescent microspheres | Q43704426 | ||
| A novel heterozygous mutation in peroxisome proliferator-activated receptor-gamma gene in a patient with familial partial lipodystrophy | Q43853009 | ||
| Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gamma | Q44381179 | ||
| A proteomic microarray approach for exploring ligand-initiated nuclear hormone receptor pharmacology, receptor selectivity, and heterodimer functionality | Q45197336 | ||
| Peptide microarrays for detailed, high-throughput substrate identification, kinetic characterization, and inhibition studies on protein kinase A. | Q46062366 | ||
| Endogenous phosphotyrosine signaling in zebrafish embryos. | Q51578637 | ||
| Advances in male contraception | Q56679619 | ||
| Analysis of ligand-dependent recruitment of coactivator peptides to RXRbeta in a time-resolved fluorescence resonance energy transfer assay | Q56894366 | ||
| Development of a coactivator displacement assay for the orphan receptor estrogen-related receptor-gamma using time-resolved fluorescence resonance energy transfer | Q56894452 | ||
| The LxxLL motif: a multifunctional binding sequence in transcriptional regulation | Q58484404 | ||
| P433 | issue | 10 | |
| P304 | page(s) | 2212-2226 | |
| P577 | publication date | 2009-07-10 | |
| P1433 | published in | Molecular & Cellular Proteomics | Q6895932 |
| P1476 | title | Nuclear receptor-coregulator interaction profiling identifies TRIP3 as a novel peroxisome proliferator-activated receptor gamma cofactor | |
| P478 | volume | 8 |
| Q64098087 | A Model of Glucocorticoid Receptor Interaction With Coregulators Predicts Transcriptional Regulation of Target Genes |
| Q57531362 | A Natural-Product Switch for a Dynamic Protein Interface |
| Q99608008 | A mutant form of ERα associated with estrogen insensitivity affects the coupling between ligand binding and coactivator recruitment |
| Q27690221 | A natural-product switch for a dynamic protein interface |
| Q34297060 | A novel RNAi lethality rescue screen to identify regulators of adipogenesis |
| Q50040433 | Allele-Specific Chromatin Recruitment and Therapeutic Vulnerabilities of ESR1 Activating Mutations |
| Q38255299 | Array-based proteomic approaches to study signal transduction pathways: prospects, merits and challenges |
| Q38656709 | Binding of bisphenol A, bisphenol AF, and bisphenol S on the androgen receptor: Coregulator recruitment and stimulation of potential interaction sites |
| Q36174638 | Co-activator candidate interactions for orphan nuclear receptor NR2E1. |
| Q38642503 | Compound A influences gene regulation of the Dexamethasone-activated glucocorticoid receptor by alternative cofactor recruitment |
| Q47220345 | Coregulator profiling of the glucocorticoid receptor in lymphoid malignancies |
| Q92449181 | Corticosteroid Action in the Brain: The Potential of Selective Receptor Modulation |
| Q38471565 | Corticosteroid receptor signalling modes and stress adaptation in the brain |
| Q92091276 | Darolutamide is a potent androgen receptor antagonist with strong efficacy in prostate cancer models |
| Q49492251 | Differential in Vitro Biological Action, Coregulator Interactions, and Molecular Dynamic Analysis of Bisphenol A (BPA), BPAF, and BPS Ligand-ERα Complexes. |
| Q50038475 | Differential modulation of FXR activity by chlorophacinone and ivermectin analogs |
| Q36835455 | Differential targeting of brain stress circuits with a selective glucocorticoid receptor modulator. |
| Q37724195 | Discovery and development of selective PPAR gamma modulators as safe and effective antidiabetic agents. |
| Q28512562 | Epidermis-type lipoxygenase 3 regulates adipocyte differentiation and peroxisome proliferator-activated receptor gamma activity |
| Q36801889 | Extending an in vitro panel for estrogenicity testing: the added value of bioassays for measuring antiandrogenic activities and effects on steroidogenesis. |
| Q37610840 | Gene expression in thiazide diuretic or statin users in relation to incident type 2 diabetes |
| Q36732823 | KLF11 mediates PPARγ cerebrovascular protection in ischaemic stroke |
| Q37776742 | Lipid signaling in the atherogenesis context |
| Q37791438 | Molecular Mechanisms and Genome-Wide Aspects of PPAR Subtype Specific Transactivation |
| Q62717494 | Natural helix 9 mutants of PPARγ differently affect its transcriptional activity |
| Q34734110 | PPARγ regulates expression of carbohydrate sulfotransferase 11 (CHST11/C4ST1), a regulator of LPL cell surface binding |
| Q37946319 | Peptide arrays for kinome analysis: new opportunities and remaining challenges |
| Q48330331 | Peptide microarray analysis of the cross-talk between O-GlcNAcylation and tyrosine phosphorylation |
| Q39791105 | Peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) but not PPARalpha serves as a plasma free fatty acid sensor in liver |
| Q24302894 | Protein Hit1, a novel box C/D snoRNP assembly factor, controls cellular concentration of the scaffolding protein Rsa1 by direct interaction |
| Q92969970 | Real-Time Monitoring of the Dephosphorylating Activity of Protein Tyrosine Phosphatases Using Microarrays with 3-Nitrophosphotyrosine Substrates |
| Q30538765 | Short-chain fatty acids stimulate angiopoietin-like 4 synthesis in human colon adenocarcinoma cells by activating peroxisome proliferator-activated receptor γ |
| Q37481267 | The AF-1-deficient estrogen receptor ERα46 isoform is frequently expressed in human breast tumors |
| Q64946029 | The SERM/SERD bazedoxifene disrupts ESR1 helix 12 to overcome acquired hormone resistance in breast cancer cells. |
| Q38900630 | The effect of quercetin and kaempferol aglycones and glucuronides on peroxisome proliferator-activated receptor-gamma (PPAR-γ). |
| Q41920358 | ZNHIT3 is defective in PEHO syndrome, a severe encephalopathy with cerebellar granule neuron loss |
Search more.